Celina Griffin

Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With <i>EGFR</i> Exon 20 Insertion–Positive Metastatic Non–Small Cell Lung Cancer

Caicun Zhou, Suresh S. Ramalingam, Tae Min Kim et al. · JAMA Oncology · 2021 · 289 citations · Full text

Medicine, Oncology, Pharmacology +15

Effects of Itraconazole and Rifampin on the Pharmacokinetics of Mobocertinib (TAK‐788), an Oral Epidermal Growth Factor Receptor Inhibitor, in Healthy Volunteers

Steven Zhang, Shu Jin, Celina Griffin et al. · Clinical Pharmacology in Drug Development · 2021 · 22 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Single‐Dose Pharmacokinetics and Tolerability of the Oral Epidermal Growth Factor Receptor Inhibitor Mobocertinib (TAK‐788) in Healthy Volunteers: Low‐Fat Meal Effect and Relative Bioavailability of 2 Capsule Products

Steven Zhang, Shu Jin, Celina Griffin et al. · Clinical Pharmacology in Drug Development · 2021 · 17 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Characterizing the Sources of Pharmacokinetic Variability for TAK‐117 (Serabelisib), an Investigational Phosphoinositide 3‐Kinase Alpha Inhibitor: A Clinical Biopharmaceutics Study to Inform Development Strategy

Chirag G. Patel, Lakshmi Rangachari, Mark Patti et al. · Clinical Pharmacology in Drug Development · 2018 · 11 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +14